There is no evidence to prove that the new crown variant strain will affect existing testing methods

China News Service, Zhuhai, May 16 (Cai Minjie and Zhang Jinju) Xu Yingchun, director of the National Center for Mycosis Surveillance Network of the National Health Commission and director of the Laboratory of Peking Union Medical College Hospital, said in an interview recently in Zhuhai, Guangdong that there is no direct evidence yet.

Under the normalization of the epidemic situation, how to quickly distinguish the new coronavirus from other respiratory pathogens and realize early diversion management? In the post-epidemic era, how to achieve rapid identification and testing of common respiratory pathogens at the grassroots level? The "2021 Chinese Medical Doctor Association Annual Meeting of Laboratory Doctors and the 16th National Laboratory and Clinical Academic Conference" was recently held in Zhuhai, Guangdong.

"For the new coronavirus, nucleic acid diagnostic technology is very important, but this technology alone is not enough.

Xu Yingchun believes that as far as infectious diseases are concerned, it is important to identify patients and quickly triage them in order to stop the rapid spread of the virus.

"Compared with the SARS outbreak in 2003, it has gone through a long period of exploration.

During the prevention and control of the new crown epidemic, grassroots prevention and control played an important role.

"We all hope that the new crown will disappear soon, but the future will be unpredictable.

On the booth of this conference, many companies displayed products related to COVID-19.

Tao Hui, deputy general manager of domestic marketing of the company, said that in order to help the development of primary medical capacity building, the company provides multi-scenario solutions such as respiratory infectious diseases and primary medical care.